Literature DB >> 29024851

Infectivity of Sf-rhabdovirus variants in insect and mammalian cell lines.

Ajay B Maghodia1, Donald L Jarvis2.   

Abstract

Sf-rhabdovirus was only recently identified as an adventitious agent of Spodoptera frugiperda (Sf) cell lines used as hosts for baculovirus vectors. As such, we still know little about its genetic variation, infectivity, and the potential impact of variation on the Sf-rhabdovirus-host interaction. Here, we characterized Sf-rhabdoviruses from two widely used Sf cell lines to confirm and extend information on Sf-rhabdovirus variation. We then used our novel Sf-rhabdovirus-negative (Sf-RVN) Sf cell line to assess the infectivity of variants with and without a 320bp X/L deletion and found both established productive persistent infections in Sf-RVN cells. We also assessed their infectivity using heterologous insect and mammalian cell lines and found neither established productive persistent infections in these cells. These results are the first to directly demonstrate Sf-rhabdoviruses are infectious for Sf cells, irrespective of the X/L deletion. They also confirm and extend previous results indicating Sf-rhabdoviruses have a narrow host range.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adventitious viruses; Baculovirus expression system; Insect cells; Sf-rhabdovirus

Mesh:

Substances:

Year:  2017        PMID: 29024851      PMCID: PMC5651996          DOI: 10.1016/j.virol.2017.09.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

Review 1.  FluBlok, a next generation influenza vaccine manufactured in insect cells.

Authors:  Manon M J Cox; Jason R Hollister
Journal:  Biologicals       Date:  2009-03-17       Impact factor: 1.856

2.  Safety testing and use of insect cells for recombinant protein production.

Authors:  Penny L Post
Journal:  PDA J Pharm Sci Technol       Date:  2010 Sep-Oct

Review 3.  Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults.

Authors:  Manon M J Cox; Ruvim Izikson; Penny Post; Lisa Dunkle
Journal:  Ther Adv Vaccines       Date:  2015-07

4.  Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines.

Authors:  Hailun Ma; Teresa A Galvin; Dustin R Glasner; Syed Shaheduzzaman; Arifa S Khan
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

Review 5.  Sipuleucel-T: in metastatic castration-resistant prostate cancer.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

6.  Established insect cell line from the cabbage looper, Trichoplusia ni.

Authors:  W F Hink
Journal:  Nature       Date:  1970-05-02       Impact factor: 49.962

7.  Identification and characterization of a novel line of Drosophila Schneider S2 cells that respond to wingless signaling.

Authors:  S Yanagawa; J S Lee; A Ishimoto
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

Review 8.  Baculovirus-insect cell expression systems.

Authors:  Donald L Jarvis
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

9.  The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera; Noctuidae).

Authors:  J L Vaughn; R H Goodwin; G J Tompkins; P McCawley
Journal:  In Vitro       Date:  1977-04

10.  Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line.

Authors:  Yoshifumi Hashimoto; Daniel Macri; Indresh Srivastava; Clifton McPherson; Rachael Felberbaum; Penny Post; Manon Cox
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

View more
  2 in total

1.  Host Range and Population Survey of Spodoptera frugiperda Rhabdovirus.

Authors:  L Schroeder; T B Mar; J R Haynes; R Wang; L Wempe; M M Goodin
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 2.  Adventitious viruses in insect cell lines used for recombinant protein expression.

Authors:  Christoph Geisler; Donald L Jarvis
Journal:  Protein Expr Purif       Date:  2017-11-10       Impact factor: 1.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.